追踪蛋白激酶向的进步:将QSAR集成到机器学习中,用于酶向药物发现
Rand Shahin1, Sawsan Jaafreh2, Yusra Azzam3
1Drug Design Unit, Department of Pharmaceutical Chemistry, Hashemite University, Zarqa, Jordan.
Future science OA
|April 4, 2025
概括
通过机器学习增强的定量结构-活性关系 (QSAR) 建模显著改善了选择性激酶抑制剂的设计. 这种方法通过克服蛋白质激酶的抗性和复杂性,加速了精密医学的药物发现.
科学领域:
- 药用化学 医学化学
- 计算生物学 计算生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 蛋白激酶是关键的药物标,但由于耐药性和激酶的复杂性,开发选择性抑制剂是困难的.
- 传统的定量结构-活性关系 (QSAR) 模型在捕捉复杂的激酶抑制剂相互作用方面存在局限性.
研究的目的:
- 审查传统QSAR与机器学习 (ML) 技术的整合,以推进酶药物发现.
- 突出深度学习增强的QSAR在设计选择性和有效的激酶抑制剂方面的潜力.
主要方法:
- 使用结构数据库,分子对接和深度学习QSAR模型.
- 集成传统的QSAR与机器学习算法,如卷积神经网络 (CNNs) 和循环神经网络 (RNNs).
- 利用来自诸如IDG-DREAM预测建模竞赛等挑战的数据.
主要成果:
- 与传统方法相比,ML集成的QSAR模型在预测激酶抑制剂相互作用方面表现优越.
- 对循环林依赖性激酶 (CDK),雅努斯激酶 (JAK) 和PIM激酶的选择性抑制剂的设计有显著的改进.
- 证明了开发具有增强选择性,有效性和耐药性缓解的抑制剂的潜力.
结论:
- 先进的计算方法,特别是深度学习增强的QSAR,正在彻底改变激酶药物发现.
- 整合QSAR与ML和实验数据加速了精密药物的开发.
- 强调可解释性和实验验证对于新激酶抑制剂的临床转化至关重要.
相关概念视频
01:28Structure-Activity Relationships and Drug Design
463
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
463
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
01:26Drug Discovery: Overview
7.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:04Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
02:15M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K